OncoBayes2 (Q52525): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Swh import (talk | contribs) SWHID from Software Heritage |
||||||||||||||
| (One intermediate revision by one other user not shown) | |||||||||||||||
| Property / source code repository | |||||||||||||||
| Property / source code repository: https://github.com/cran/OncoBayes2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Software Heritage ID | |||||||||||||||
| Property / Software Heritage ID: swh:1:snp:d9a2dc45a343cd68fc140be86cacebc6c0b79661 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Software Heritage ID: swh:1:snp:d9a2dc45a343cd68fc140be86cacebc6c0b79661 / qualifier | |||||||||||||||
| Property / Software Heritage ID: swh:1:snp:d9a2dc45a343cd68fc140be86cacebc6c0b79661 / qualifier | |||||||||||||||
point in time: 17 August 2023
| |||||||||||||||
Latest revision as of 02:33, 22 March 2024
Bayesian Logistic Regression for Oncology Dose-Escalation Trials
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OncoBayes2 |
Bayesian Logistic Regression for Oncology Dose-Escalation Trials |
Statements
20 July 2023
0 references
Bayesian logistic regression model with optional EXchangeability-NonEXchangeability parameter modelling for flexible borrowing from historical or concurrent data-sources. The safety model can guide dose-escalation decisions for adaptive oncology Phase I dose-escalation trials which involve an arbitrary number of drugs. Please refer to Neuenschwander et al. (2008) <doi:10.1002/sim.3230> and Neuenschwander et al. (2016) <doi:10.1080/19466315.2016.1174149> for details on the methodology.
0 references
